Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders
Jatin Machhi, Bhavesh D. Kevadiya, Ijaz Khan Muhammad, et al.
Molecular Neurodegeneration (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

The reciprocal interactions between microglia and T cells in Parkinson’s disease: a double-edged sword
Yuxiang Xu, Yongjie Li, Changqing Wang, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 46
Causal relationship between immune cells and neurodegenerative diseases: a two-sample Mendelian randomisation study
Chao Tang, Xiaoyang Lei, Yaqi Ding, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 19
CNS implications of COVID-19: a comprehensive review
Priyanka Nagu, Arun Parashar, Tapan Behl, et al.
Reviews in the Neurosciences (2020) Vol. 32, Iss. 2, pp. 219-234
Open Access | Times Cited: 123
CD4+ effector T cells accelerate Alzheimer’s disease in mice
Jatin Machhi, Pravin Yeapuri, Yaman Lu, et al.
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 93
Nanocarrier vaccines for SARS-CoV-2
Jatin Machhi, Farah Shahjin, Srijanee Das, et al.
Advanced Drug Delivery Reviews (2021) Vol. 171, pp. 215-239
Open Access | Times Cited: 92
Regulatory T cells in ischemic stroke
Hongyun Wang, Jun-rui Ye, Liyuan Cui, et al.
Acta Pharmacologica Sinica (2021) Vol. 43, Iss. 1, pp. 1-9
Open Access | Times Cited: 58
Adoptive therapy with amyloid-β specific regulatory T cells alleviates Alzheimer's disease
Hyejin Yang, Seon‐Young Park, Hyunjung Baek, et al.
Theranostics (2022) Vol. 12, Iss. 18, pp. 7668-7680
Open Access | Times Cited: 39
Amyloid-β specific regulatory T cells attenuate Alzheimer’s disease pathobiology in APP/PS1 mice
Pravin Yeapuri, Jatin Machhi, Yaman Lu, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 26
Regulatory T cells promote functional recovery after spinal cord injury by alleviating microglia inflammation via STAT3 inhibition
Rui Liu, Ying Li, Ziyue Wang, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 8, pp. 2129-2144
Open Access | Times Cited: 25
Recent Development in the Understanding of Molecular and Cellular Mechanisms Underlying the Etiopathogenesis of Alzheimer’s Disease
Atefeh Afsar, Maria del Carmen Chacon Castro, Adedamola Saidi Soladogun, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7258-7258
Open Access | Times Cited: 23
Brain regulatory T cells
Adrian Liston, Emanuela Pasciuto, Denise Fitzgerald, et al.
Nature reviews. Immunology (2023) Vol. 24, Iss. 5, pp. 326-337
Closed Access | Times Cited: 23
Targeting brain-peripheral immune responses for secondary brain injury after ischemic and hemorrhagic stroke
Mingxu Duan, Ya Xu, Yuanshu Li, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Regulatory T cells limit age-associated retinal inflammation and neurodegeneration
María Llorián‐Salvador, Alerie Guzman de la Fuente, Christopher E McMurran, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 11
T cell activation and deficits in T regulatory cells are associated with major depressive disorder and severity of depression
Muanpetch Rachayon, Ketsupar Jirakran, Pimpayao Sodsai, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Chitinase-3-like-1: a multifaceted player in neuroinflammation and degenerative pathologies with therapeutic implications
Pharaoh Fellow Mwale, Cheng-Ta Hsieh, Ting‐Lin Yen, et al.
Molecular Neurodegeneration (2025) Vol. 20, Iss. 1
Open Access | Times Cited: 1
Immune Cell-NSPC Interactions: Friend or Foe in CNS Injury and Repair?
Chih‐Wei Zeng
Differentiation (2025) Vol. 143, pp. 100855-100855
Closed Access | Times Cited: 1
Ex vivo expansion of dysfunctional regulatory T lymphocytes restores suppressive function in Parkinson’s disease
Aaron D. Thome, Farah Atassi, Jinghong Wang, et al.
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 51
Sargramostim (rhu GM-CSF) as Cancer Therapy (Systematic Review) and An Immunomodulator. A Drug Before Its Time?
Hillard M. Lazarus, Carolyn E. Ragsdale, Robert Peter Gale, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 47
Therapeutic Potential of a Combination of Electroacupuncture and Human iPSC-Derived Small Extracellular Vesicles for Ischemic Stroke
Peiying Deng, Liang Wang, Qiongqiong Zhang, et al.
Cells (2022) Vol. 11, Iss. 5, pp. 820-820
Open Access | Times Cited: 30
The potential for treg-enhancing therapies in nervous system pathologies
Katherine E. Olson, R. Lee Mosley, Howard E. Gendelman
Clinical & Experimental Immunology (2022) Vol. 211, Iss. 2, pp. 108-121
Open Access | Times Cited: 30
Calcitriol restrains microglial M1 polarization and alleviates dopaminergic degeneration in hemiparkinsonian mice by boosting regulatory T‐cell expansion
Yangzhi Xie, Liang Chen, Jiacheng Chen, et al.
Brain and Behavior (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 6
Tissue Tregs and Maintenance of Tissue Homeostasis
Qing Shao, Jian Gu, Jinren Zhou, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 40
Safety, tolerability, and immune-biomarker profiling for year-long sargramostim treatment of Parkinson's disease
Katherine E. Olson, Krista L. Namminga, Yaman Lu, et al.
EBioMedicine (2021) Vol. 67, pp. 103380-103380
Open Access | Times Cited: 39
Genetic Defects and Pro-inflammatory Cytokines in Parkinson's Disease
Albert Frank Magnusen, Shelby Loraine Hatton, Reena Rani, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 36
Cellular and molecular influencers of neuroinflammation in Alzheimer's disease: Recent concepts & roles
Powsali Ghosh, Ravi Bhushan Singh, Ankit Ganeshpurkar, et al.
Neurochemistry International (2021) Vol. 151, pp. 105212-105212
Closed Access | Times Cited: 36
Page 1 - Next Page

Scroll to top